PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
oleh: Lucia Masarova, Srdan Verstovsek, Tom Liu, Sumati Rao, Guatam Sajeev, Ryan Simpson, Weilong LI, Joseph Yang, Boris Gorsh, James Signorovitch
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2023-08-01 |
Deskripsi
No description available for this item.